Careers  |  Sign In  |  Register  |   Twitter

Hot Topics in HIV Management

 
Course List


  • CME/CPE Information

Provider Statements

These continuing medical education activities are provided by National Jewish Health.

National Jewish Health

These continuing pharmacy education activities are provided by Vindico Medical Education.

Vindico Medical Education

Support Statement

These activities are supported by an educational grant from ViiV Healthcare.

Overview

Antiretroviral therapy has improved dramatically over the past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already diverse field of HIV. Clinicians must keep up with new data on treatment strategies, selection of appropriate individualized therapy, and effective management of patient side effects. In these interactive, case-based activities, expert faculty will convey how to incorporate new treatment strategies into clinical practice and discuss various aspects of HIV management, including selecting an initial antiretroviral regimen, modifying therapy in virologically suppressed patients, and selecting the optimal approach for those with treatment failure.

Target Audience

The intended audience for these activities is infectious disease specialists, HIV treaters, pharmacists, and other health care professionals involved in the treatment of patients with HIV.

Learning Objectives

Upon successful completion of these activities, participants should be better able to:

  • Apply updated evidence-based guidelines and recommendations when selecting initial treatment for patients with human immunodeficiency virus (HIV)
  • Select and optimize HIV treatment regimens based on clinical safety and efficacy, propensity for resistance, and patient characteristics.
  • Consider patient preferences when selecting HIV treatment regimens to increase adherence and compliance to therapy.
  • Implement effective switching strategies, as necessary, in patients who are virologically suppressed, have become virologically resistant to therapy, or who have become nonadherent.

Activity Chair

Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, MA

Faculty

Richard A. Elion, MD
Clinical Professor of Medicine
George Washington University School of Medicine
Co-Director, HIV/HCV Treatment and Research Program
Providence Hospital
Washington, DC

Joseph J. Eron, Jr., MD
Professor of Medicine
Division of Infectious Diseases
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, NC

Babafemi O. Taiwo, MBBS
Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, IL

Accreditation

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Credit Designation

National Jewish Health designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™, 0.25 credits per activity. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Video 1
This program is acceptable for 0.25 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is 0482-9999-17-010-H02-P, effective 12/28/2017. This is a knowledge-based activity, and there is no fee to attend.

Video 2
This program is acceptable for 0.25 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is 0482-9999-17-011-H02, effective 12/28/2017. This is a knowledge-based activity, and there is no fee to attend.

Video 3
This program is acceptable for 0.25 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is 0482-9999-17-012-H02, effective 12/28/2017. This is a knowledge-based activity, and there is no fee to attend.

This enduring material is approved for 1 year from the date of original release, December 28, 2017 to December 28, 2018.

How to Participate in this Activity and Obtain CME/CPE Credit

To participate in these CME/CPE activities, you must read the objectives, answer the pretest questions, view the content, complete the CME posttests, and complete the evaluations. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering all (100%) of the posttest questions correctly for each activity (two questions for video 1 and one question each for videos 2 and 3). Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, National Jewish Health will issue an AMA PRA Category 1 Credit(s)™ Certificate or Vindico Medical Education will issue an ACPE Continuing Education Credit(s)™ Certificate.

Reviewers

Jennifer Cocohoba, PharmD, MAS, BCPS, AAHIVP
Lisa Hightow-Weidman, MD, MPH

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education and Accreditation Council for Pharmacy Education’s Standards for Commercial Support, all CME/CPE providers are required to disclose to the activity audience the relevant financial relationships of the planners, faculty, and reviewers involved in the development of CME/CPE content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME/CPE activity content over which the individual has control. Relationship information appears below.

Activity Chair and Faculty Members report the following relationship(s):

Richard A. Elion, MD
Consulting Fee: Gilead, ViiV
Speakers Bureau: Gilead, Janssen
Advisor: Gilead, ViiV
Expert Witness: Gilead

Joseph J. Eron, Jr., MD
Consulting Fee: Gilead, Janssen, Merck, ViiV
Contracted Research (Paid to Institution): Gilead, Janssen, ViiV

Paul E. Sax, MD
Consulting Fee: AbbVie, Bristol-Myers Squibb, Gilead, GlaxoSmithKline/ViiV, Janssen, Merck
Contracted Research: Bristol-Myers Squibb, Gilead, GlaxoSmithKline/ViiV

Babafemi O. Taiwo, MBBS
Consulting Fee: Gilead, GlaxoSmithKline, Merck, ViiV
Contracted Research: GlaxoSmithKline, ViiV

Reviewers report the following relationship(s):

Jennifer Cocohoba, PharmD, MAS, BCPS, AAHIVP
No relevant financial relationships to disclose.

Lisa Hightow-Weidman, MD, MPH
No relevant financial relationships to disclose.

National Jewish Health and Vindico Medical Education staff report the following relationship(s):

No relevant financial relationships to disclose.

Signed disclosures are on file at National Jewish Health and Vindico Medical Education, Offices of Medical Affairs and Compliance.

Educational Tools

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of National Jewish Health and Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of National Jewish Health and Vindico Medical Education. Neither National Jewish Health, Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME/CPE Questions?

Contact us at CME@VindicoCME.com